Literature DB >> 24386926

Cardiac amyloidosis.

Syed Wamique Yusuf1, Amirreza Solhpour, Jose Banchs, Juan C Lopez-Mattei, Jean-Bernard Durand, Cezar Iliescu, Saamir A Hassan, Muzaffar H Qazilbash.   

Abstract

Amyloidosis is a condition characterized by the extracellular deposition of insoluble fibrillar protein in tissues and various organs including the heart. This review summarizes the clinical manifestations and diagnostic treatment approaches for cardiac amyloidosis.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24386926     DOI： 10.1586/14779072.2014.876363

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN： 1477-9072


  12 in total

Review 1.  Advances in Treatment of Cardiac Amyloid.

Authors:  Cherie N Dahm; R Frank Cornell; Daniel J Lenihan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-04-07

Review 2.  Proteotoxicity and cardiac dysfunction.

Authors:  Patrick M McLendon; Jeffrey Robbins
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

3.  Frequent MUGA testing in a myeloma patient: A case-based ethics discussion.

Authors:  Sabha Bhatti; Robert C Hendel; Juan Lopez-Mattei; Ronald G Schwartz; Gilbert Raff; Andrew J Einstein
Journal:  J Nucl Cardiol       Date:  2016-06-06       Impact factor: 5.952

4.  Cardiac amyloidosis imaging with amyloid positron emission tomography: A systematic review and meta-analysis.

Authors:  Yong Joong Kim; Sejin Ha; Yong-Il Kim
Journal:  J Nucl Cardiol       Date:  2018-07-18       Impact factor: 5.952

Review 5.  Recent advances in the noninvasive strategies of cardiac amyloidosis.

Authors:  Lei Zhao; Quan Fang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

6.  Cerebral embolism secondary to cardiac amyloidosis: A case report and literature review.

Authors:  Xu-Dong Zhang; Ying-Xian Liu; Xiao-Wei Yan; Li-Gang Fang; Quan Fang; Da-Chun Zhao; Yi-Ning Wang
Journal:  Exp Ther Med       Date:  2017-10-13       Impact factor: 2.447

7.  [The prognostic value of baseline serum free light chain in immunoglobulin light-chain cardiac amyloidosis].

Authors:  L M Wang; T T Wang; Y Tian; L Zhao; X C Yang; W M Chen
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14

8.  Dysfunction of the CNS-heart axis in mouse models of Huntington's disease.

Authors:  Michal Mielcarek; Linda Inuabasi; Marie K Bondulich; Thomas Muller; Georgina F Osborne; Sophie A Franklin; Donna L Smith; Andreas Neueder; Jim Rosinski; Ivan Rattray; Andrea Protti; Gillian P Bates
Journal:  PLoS Genet       Date:  2014-08-07       Impact factor: 5.917

Review 9.  Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis.

Authors:  Lei Zhao; Zhuang Tian; Quan Fang
Journal:  BMC Cardiovasc Disord       Date:  2016-06-07       Impact factor: 2.298

10.  Cardiac amyloidosis presenting with recurrent ischaemic strokes.

Authors:  Suleiman Suleiman; John Joseph Coughlan; David Moore
Journal:  BMJ Case Rep       Date:  2020-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.